XML 26 R29.htm IDEA: XBRL DOCUMENT
v3.20.1

Revenue (Tables) | 6 Months Ended
--- | ---
Mar. 28, 2020
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:
|  | Three Months Ended March 28, 2020 |  | Three Months Ended March 30, 2019
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 73.2 |  | $ | 40.2 |  | $ | 113.4 |  |  | $ | 76.6 |  | $ | 38.9 |  | $ | 115.5 |
| Molecular Diagnostics | 149.8 |  | 40.8 |  | 190.6 |  |  | 136.8 |  | 31.0 |  | 167.8 |
| Blood Screening | 15.2 |  | — |  | 15.2 |  |  | 13.4 |  | — |  | 13.4 |
Total | $ | 238.2 |  | $ | 81.0 |  | $ | 319.2 |  |  | $ | 226.8 |  | $ | 69.9 |  | $ | 296.7 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 186.0 |  | $ | 64.2 |  | $ | 250.2 |  |  | $ | 206.2 |  | $ | 59.7 |  | $ | 265.9 |
| Interventional Breast Solutions | 48.4 |  | 9.2 |  | 57.6 |  |  | 46.8 |  | 8.8 |  | 55.6 |
Total | $ | 234.4 |  | $ | 73.4 |  | $ | 307.8 |  |  | $ | 253.0 |  | $ | 68.5 |  | $ | 321.5 |
GYN Surgical | $ | 86.7 |  | $ | 18.7 |  | $ | 105.4 |  |  | $ | 84.1 |  | $ | 18.1 |  | $ | 102.2 |
Medical Aesthetics | $ | — |  | $ | — |  | $ | — |  |  | $ | 37.6 |  | $ | 36.2 |  | $ | 73.8 |
Skeletal Health | $ | 15.6 |  | $ | 8.1 |  | $ | 23.7 |  |  | $ | 14.0 |  | $ | 10.2 |  | $ | 24.2 |
|  | $ | 574.9 |  | $ | 181.2 |  | $ | 756.1 |  |  | $ | 615.5 |  | $ | 202.9 |  | $ | 818.4 |
|  | Six Months Ended March 28, 2020 |  | Six Months Ended March 30, 2019
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 150.7 |  | $ | 83.7 |  | $ | 234.4 |  |  | $ | 155.8 |  | $ | 77.8 |  | $ | 233.6 |
| Molecular Diagnostics | 291.9 |  | 77.2 |  | 369.1 |  |  | 270.9 |  | 61.2 |  | 332.1 |
| Blood Screening | 27.2 |  | — |  | 27.2 |  |  | 27.6 |  | — |  | 27.6 |
Total | $ | 469.8 |  | $ | 160.9 |  | $ | 630.7 |  |  | $ | 454.3 |  | $ | 139.0 |  | $ | 593.3 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 395.4 |  | $ | 129.6 |  | $ | 525.0 |  |  | $ | 412.7 |  | $ | 122.9 |  | $ | 535.6 |
| Interventional Breast Solutions | 95.5 |  | 18.4 |  | 113.9 |  |  | 92.9 |  | 17.7 |  | 110.6 |
Total | $ | 490.9 |  | $ | 148.0 |  | $ | 638.9 |  |  | $ | 505.6 |  | $ | 140.6 |  | $ | 646.2 |
GYN Surgical | $ | 185.5 |  | $ | 39.0 |  | $ | 224.5 |  |  | $ | 175.2 |  | $ | 35.4 |  | $ | 210.6 |
Medical Aesthetics | $ | 30.9 |  | $ | 34.4 |  | $ | 65.3 |  |  | $ | 74.9 |  | $ | 78.7 |  | $ | 153.6 |
Skeletal Health | $ | 30.5 |  | $ | 16.7 |  | $ | 47.2 |  |  | $ | 27.2 |  | $ | 18.2 |  | $ | 45.4 |
|  | $ | 1,207.6 |  | $ | 399.0 |  | $ | 1,606.6 |  |  | $ | 1,237.2 |  | $ | 411.9 |  | $ | 1,649.1 |
|  | Three Months Ended |  | Six Months Ended
Geographic Regions (in millions) |  | March 28, 2020 | March 30, 2019 |  | March 28, 2020 | March 30, 2019
United States |  | $ | 574.9 |  | $ | 615.5 |  |  | $ | 1,207.6 |  | $ | 1,237.2 |
Europe |  | 111.8 |  | 102.1 |  |  | 221.2 |  | 203.2 |
Asia-Pacific |  | 41.7 |  | 64.3 |  |  | 111.8 |  | 134.0 |
Rest of World |  | 27.7 |  | 36.5 |  |  | 66.0 |  | 74.7 |
|  | $ | 756.1 |  | $ | 818.4 |  |  | $ | 1,606.6 |  | $ | 1,649.1 |
The following table provides revenue recognized by source:
|  | Three Months Ended |  | Six Months Ended
Revenue by type (in millions) |  | March 28, 2020 | March 30, 2019 |  | March 28, 2020 | March 30, 2019
Capital equipment, components and software |  | $ | 166.6 |  | $ | 239.4 |  |  | $ | 399.5 |  | $ | 487.8 |
Consumables |  | 457.0 |  | 428.4 |  |  | 923.4 |  | 863.1 |
Service |  | 127.2 |  | 141.1 |  |  | 272.2 |  | 283.0 |
Other |  | 5.3 |  | 9.5 |  |  | 11.5 |  | 15.2 |
|  | $ | 756.1 |  | $ | 818.4 |  |  | $ | 1,606.6 |  | $ | 1,649.1 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration